Valerio Nobili

Valerio Nobili

Artigo(s) publicado(s) :

 

Born in Milan on 10/04/1966

29/10/1990 Honour Medical Degree (110/110) in Rome University “La Sapienza”

28/10/1994 Post-graduate Degree (70/70) in Pediatrics in Rome University “La Sapienza”

10/11/1995 Specialisation Course in Neonatal Intensive Care in the Institute of Pediatric Clinic of Rome University “La Sapienza”

During his Specialisation Course he worked diligently in the Department of Pediatric Clinic of the General Hospital Umberto I carrying on activities of caring and research.

January – August 1993 Scientific Research in the Department of Gastoenterology of St Thomas’ Hospital of London. During this period he has particularly studied indirect-cell intestinal immunity. He has widely published the results of this research in international reviews.

From September 1995 to July 1998 he has carried on his professional activity in Neonatology Department and in Neonatal Patology of Aurelia Hospital.

From September 1995 to 30/04/1999 he has worked as Assistant in the Pediatric Department of S. Pietro Hospital in Rome.

January – August 2004 and June – August 2007 as Consultant in the Liver Unit of King’s College Hospital of London.

From May 1999 to nowadays he has been carrying on his professional activity as Medical Manager I° level in Bambino Gesù Pediatric Hospital in Rome (first in Emergency Department then from 2002 in Hepatology Department). Actually, he is the Head of Metabolic and Autoimmunity Liver Disease section and the Chief of Liver Research Unit.

Since September 2011 he is the Vice-President of SIGENP (Italian Society Gastro Hepato Nutrition Pediatric). He is also a member of the Hepatology Committee of the ESPGHAN (European Society Gastro Hepatology Nutrition Pediaric)

He is reviewer for the following medical Journal: Hepatology, GUT, Journal Gastroenterology and Hepatology, Journal Pediatric Gastroenterology and Nutrition, World Journal Gastroenterology, Journal of Hepatology, Liver International, Pediatric Transplantation, Expert Review of Molecular Diagnostics, Journal of Hematology, Journal of Internal Medicine, Journal of Clinical Rheumatology, Clinical Endocrinology

He has published many works in international reviews (more than 200) and he has attended many national and international Congresses as reporter.

 

Bibliografia:

Articoli

  1. Barbato M; Frediani, T; Lucarelli S; Viola F; Iulinella V R, Cao M, Contestabile G, Farinelli C, Principessa L, Nobili, V. A comparison between antigliadin antibodies and blood xylose in celiac disease. Minerva Pediatr. 1991 Sep;43(9):563-6.
  2. Przemioslo RT, Kontakou M, Nobili V, Ciclitira PJ. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut. 1994 Oct;35(10):1398-403.
  3. Curti L; Corrado G; Semeraro P, Capuano M, Cavaliere M, Pacchiarotti C, Barbato M, Nobili V. Orbital cellulitis in pediatric age. Report of a case and review of the literature. Clin Ter. 1995 Apr; 146( 4): 297-307.
  4. Nobili V, Comparcola D, Sartorelli MR, Devito R, Marcellini M. Autoimmune hepatitis type 1 after Epstein-Barr virus infection. Pediatr Infect Dis J. 2003 Apr;22(4):387.
  5. Nobili V, Comparcola D, Sartorelli MR, Natali G, Monti L, Falappa P, Marcellini M. Blind and ultrasound-guided percutaneous liver biopsy in children. Pediatr Radiol. 2003 Nov;33(11):772-5.
  6. Nobili V, Comparcola D, Sartorelli MR, Diciommo V, Marcellini M. Mycophenolate mofetil in pediatric liver transplant patients with renal dysfunction: preliminary data. Pediatr Transplant. 2003 Dec;7(6):454-7.
  7. Nobili V, Marcellini M, Devito R, Capolino R, Viola R, Digilio MC. Hepatic fibrosis in Kabuki syndrome. Am J Med Genet A. 2004 Jan;15;124A(2):209-12.
  8. Nobili V, Vento S, Comparcola D, Sartorelli MR, Luciani M, Marcellini M. Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection. Pediatr Infect Dis J. 2004 Feb;23(2):184-5.
  9. Nobili V, Marcellini M, Giovannelli L, Girolami E, Muratori F, Giannone G, Devito R, De Benedetti F. Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):540-4.
  10. Nobili V, Devito R, Comparcola D, Cortis E, Sartorelli MR, Marcellini M. Juvenile idiopathic arthritis associated with autoimmune hepatitis type 2. Ann Rheum Dis. 2005 Jan;64(1):157-8.
  11. Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, Carelli G, Nobili V. Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med. 2005 Mar;145(3):139-43.
  12. Visco G, Bellanti F, Campanella L, Mazzella T, Nobili V. Optimisation of a photochemical sensor for total organic carbon measurement. Ann Chim. 2005 Mar-Apr;95(3-4):185-98
  13. Nobili V, Pastore A, Gaeta LM, Tozzi G, Comparcola D, Sartorelli MR, Marcellini M, Bertini E, Piemonte F. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta. 2005 May;355(1-2):105-11.
  14. Nobili V, Maggi F, Diciommo V, Caione D, Marcellini M, Bendinelli M. Is torquetenovirus a potential cause of liver damage in children? J Infect. 2005 May;50(4):368-9.
  15. Nobili V, Liaskos C, Luigi G, Guidi R, Francalanci P, Marcellini M. Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid. 2005 Oct;15(10):1193-5.
  16. Ortona E, Margutti P, Delunardo F, Nobili V, Profumo E, Riganò R, Buttari B, Carulli G, Azzarà A, Teggi A, Bruschi F, Siracusano A. Screening of an Echinococcus granulosus cDNA library with IgG4 from patients with cystic echinococcosis identifies a new tegumental protein involved in the immune escape. Clin Exp Immunol. 2005 Dec;142(3):528-38.
  17. Nobili V. Nutritional considerations in children with chronic liver disease. J Gastroenterol Hepatol. 2005 Dec;20(12):1805-6.
  18. Comparcola D, Nobili V, Sartorelli MR, Marcellini M, Cainelli F, Vento S. Childhood hepatitis C virus infection. J Gastroenterol Hepatol. 2005 Dec;20(12):1948-9.
  19. Nobili V, Vento S, Dionisi C, Sartorelli MR, Russo C, Marcellini M. Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):339.
  20. Vento S, Nobili V, Cainelli F. Clinical course of infection with hepatitis C. BMJ. 2006 Feb 18;332(7538):374-5.
  21. Ferraris A, D’Amato G, Nobili V, Torres B, Marcellini M, Dallapiccola B. Combined test for UGT1A1 -3279T–>G and A(TA)nTAA polymorphisms best predicts Gilbert’s syndrome in Italian pediatric patients. Genet Test. 2006 Summer;10(2):121-5.
  22. Nobili V, Di Giandomenico S, Francalanci P, Callea F, Marcellini M, Santorelli FM. A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis. J Gastroenterol. 2006 Jun;41(6):598-603.
  23. Nobili V, Marcellini M, Devito R, Comparcola D, Vento S. Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl. Eur J Gastroenterol Hepatol. 2006 Aug;18(8):927-9.
  24. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006 Aug;44(2):458-65.
  25. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, Comparcola D, Guidi R, Marcellini M. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol. 2006 Nov;155(5):735-43.
  26. Comparcola D, Nobili V, Marcellini M. HCV and steatosis in children. J Hepatol. 2006 Nov;45(5):758; author reply 758-9.
  27. Iacobellis A, Marcellini M, Andriulli A, Perri F, Leandro G, Devito R, Nobili V. Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol. 2006 Dec 28;12(48):7821-5.
  28. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2006 Dec;24(11-12):1553-61.
  29. Marcellini M, Sartorelli MR, Nobili V. Reply to T.U. Hoogenraad’s paper published last April. Zinc therapy in Wilson’s disease. Brain Dev. 2007 Jan;29(1):55.
  30. Guidi R, Nobili V, Marcellini M. Food allergy in pediatric liver transplant recipients: harmful or harmless? Pediatr Transplant. 2007 Feb;11(1):1-2.
  31. De Paolis P, Nobili V, Lombardi A, Tarasi D, Barbato D, Marchitti S, Ganten U, Brunetti E, Volpe M, Rubattu S. Role of a molecular variant of rat atrial natriuretic Peptide gene in vascular remodeling.Ann Clin Lab Sci. 2007 Spring;37(2):135-40.
  32. Manco M, Marcellini M, Nobili V. Lifestyle advice in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007 Apr;22(4):604-5.
  33. Nobili V, Manco M, Raponi M, Marcellini M. Case management in children affected by non-alcoholic fatty liver disease. J Paediatr Child Health. 2007 May;43(5):414.
  34. Nobili V, Manco M. Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. World J Gastroenterol. 2007 May 14;13(18):2639-41.
  35. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007 Jun;127(6):954-60.
  36. Nobili V, Pietro S, Stefania P. Fulminant hepatic failure following measles. Pediatr Infect Dis J. 2007 Aug;26(8):766-7.
  37. Alisi A, Nobili V. Molecular pathogenesis of nonalcoholic steatohepatitis: today and tomorrow. Am J Pathol. 2007 Aug;171(2):712-3; author reply 713.
  38. Nobili V, Manco M. Measurement of advanced glycation end products may change NASH management. J Gastroenterol Hepatol. 2007 Sep;22(9):1354-5.
  39. Manco M, Marcellini M, Nobili V. How much we worry for liver fat in children? Acta Paediatr. 2007 Sep;96(9):1373-4; author reply 1374-5.
  40. Nobili V, Marcellini M, Marchesini G, Vanni E, Manco M, Villani A, Bugianesi E. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007 Oct;30(10):2638-40.
  41. Manco M, Nobili V. Different fat distribution as marker of disease in nonalcholic fatty liver disease. Hepatology. 2007 Oct;46(4):1310-1; author reply 1312.
  42. Alisi A, Marcellini M, Nobili V. Bioinformatics as tool to identify gene/protein-pathways associated with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 2007 Oct;46(4):1306; author reply 1306-7.
  43. Alisi A, Nobili V. Molecular genetics of NASH: the role of polymorphisms. J Hepatol. 2007 Dec;47(6):868-9; author reply 870-1.
  44. Belleudi F, Leone L, Nobili V, Raffa S, Francescangeli F, Maggio M, Morrone S, Marchese C, Torrisi MR. Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways.Traffic. 2007 Dec;8(12):1854-72.
  45. Nobili V, Devito R, Dall’oglio L, Cainelli F, Giustiniani P, Girolami E, Marcellini M. Autoimmune sclerosing cholangitis in two sisters. Eur J Pediatr. 2008 Jan;167(1):107-8.
  46. Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G, Manco M. Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. Diabetes Care. 2008 Jan;31(1):3-8.
  47. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond). 2008 Feb;32(2):381-7.
  48. Manco M, Nobili V. Intensive treatment and dietary fats in adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):224.
  49. Piemonte F, Petrini S, Gaeta LM, Tozzi G, Bertini E, Devito R, Boldrini R, Marcellini M, Ciacco E, Nobili V. Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e457-64.
  50. Lintas C, Cappa M, Comparcola D, Nobili V, Fierabracci A. An 8-year-old boy with autoimmune hepatitis and Candida onychosis as the first symptoms of autoimmune polyglandular syndrome (APS1): identification of a new homozygous mutation in the autoimmune regulator gene (AIRE). Eur J Pediatr. 2008 Aug;167(8):949-53.
  51. Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, Comparcola D, Piemonte F, Nobili V. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut. 2008 Sep;57(9):1283-7.
  52. Nobili V, Dhawan A. Are children after liver transplant more prone to non-alcoholic fatty liver disease? Pediatr Transplant. 2008 Sep;12(6):611-3.
  53. Vento S, Nobili V. Aminotransferases as predictors of mortality. Lancet. 2008 May 31;371(9627):1822-3.
  54. Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, Day CP, Reeves HL. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology. 2008 Jul;135(1):282-291.e1.
  55. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008 Jul;48(1):119-28.
  56. Manco M, Nobili V. Beta-cell glucose sensitivity in patients with liver fibrosis. Gut. 2008 Jul;57(7):1023.
  57. Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008 Aug;48(2):442-8.
  58. Diamanti A, Basso MS, Pietrobattista A, Nobili V. Prevalence of celiac disease in children with autoimmune hepatitis. Dig Liver Dis. 2008 Dec;40(12):965.
  59. Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther. 2008 Jun;30(6):1168-76.
  60. Manco M, Nobili V. Reduced cardio-respiratory fitness in obesity with and without nonalcoholic fatty liver disease. Hepatology. 2008 Aug;48(2):690; author reply 690-1.
  61. Manco M, Giordano U, Turchetta A, Fruhwirth R, Ancinelli M, Marcellini M, Nobili V. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease. Acta Diabetol. 2008 Oct; 46(2):97-104
  62. Manco M, Alisi A, Nobili V. Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. Hepatology. 2008 Dec;48(6):2087-8; author reply 2088.
  63. Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G, Nobili V. Nonalcoholic fatty liver disease in children. J Am Coll Nutr. 2008 Dec;27(6):667-76.
  64. Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, Vizzutti F, Pinzani M, Rosenberg WM. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology. 2009 Jan;136(1):160-7.
  65. Alisi A, Masotti A, Nobili V. Profiling microRNA expression: a snapshot of nonalcoholic steatohepatitis and a recording of its pathogenesis. Hepatology. 2009 Feb;49(2):706-7.
  66. Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, Manco M, Feldstein AE. Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2009 May;7(5):575-9.
  67. Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med. 2009 May 1;7:21
  68. Manco M, Ciampalini P, Devito R, Vania A, Cappa M, Nobili V. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. Pediatr Nephrol. 2009 Jun;24(6):1211-7.
  69. Balsano C, Alisi A, Nobili V. Liver fibrosis and therapeutic strategies: the goal for improving metabolism. Curr Drug Targets. 2009 Jun;10(6):505-12
  1. Manco M, Giordano U, Turchetta A, Fruhwirth R, Ancinelli M, Marcellini M, Nobili V. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease. Acta Diabetol. 2009 Jun;46(2):97-104.
  2. Alisi A, Devito R, Nobili V. Portal inflammation as index of steatohepatitis in children with nonalcoholic fatty liver disease. Hepatology. 2009 Aug;50(2):659.
  3. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Alterio A, Tiribelli C, Agostoni C. A protective effect of breastfeeding on progression of nonalcoholic fatty liver disease. Arch Dis Child. Arch Dis Child. 2009 Oct;94(10):801-5.
  4. Nobili V, Reale A, Alisi A, Morino G, Trenta I, Pisani M, Marcellini M, Raucci U. Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. Dig Liver Dis. 2009 Oct;41(10):749-52.
  1. Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Ann Hepatol. 2009;8 Suppl 1:S44-50.
  1. Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, Laffi G, Marra F, Pinzani M. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol. 2009 Apr-Jun;8(2):89-94.
  1. Manco M, Nobili V. Utility of magnetic resonance imaging in the evaluation of hepatic fat content.Hepatology. 2009 Jul;50(1):328-9; author reply 329.
  1. Pietrobattista A, Fruwirth R, Natali G, Monti L, Devito R, Nobili V. Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension. Pediatr Radiol. 2009 Sep;39(9):959-61
  2. Alisi A, Piemonte F, Pastore A, Panera N, Passarelli C, Tozzi G, Petrini S, Pietrobattista A, Bottazzo GF, Nobili V. Glutathionylation of p65NF-kB correlates with proliferating/apoptotic hepatoma cells exposed to pro-and anti-oxidants. Int J Mol Med. 2009 Sep;24(3):319-26.
  1. Alisi A, Manco M, Vania A, Nobili V. Pediatric Nonalcoholic Fatty Liver disease in 2009. J Pediatr. 2009 Oct;155(4):469-74.
  1. Nobili V, and Day C. Childhood NAFLD: a ticking time-bomb? 2009 Nov;58(11):1442.
  1. Nobili V, Alisi A, Pietrobattista A, Amendola S, Somma R, Gennari F, de Ville de Goyet J. Psychosocial condition after liver transplantation in children: review of the literature from 2006 to 2008. Transplant Proc. 2009 Nov;41(9):3779-83.
  2. Alisi A, Pinzani M, Nobili V. Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology. 2009 Dec;50(6):2048-9; author reply 2049-50.
  3. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol. 2009 Dec 28;15(48):6017-22.
  1. Alisi A, Panera N, Nobili V. Toll like receptor 4 in children affected by NASH. 2010 Feb;51(2):714-5.
  1. Manco M, Bedogni G, Monti L, Morino G, Natali G, Nobili V. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis. 2010 Apr;209(2):463-8.
  1. Nobili V, Agostoni C. Clinical observation paper: fatty liver and metabolic syndrome: is it a burden for the future generations? Metabolism. 2010 Jun;59(6):831-3.
  1. Comparcola D, Alisi A, Nobili V. Hepatitis C virus and nonalcoholic Fatty liver disease: similar risk factors for necroinflammation, fibrosis, and cirrhosis.Clin Gastroenterol Hepatol. 2010 Jan;8(1):97; author reply 97.
  1. Sartorelli MR, Comparcola D, Nobili V. Acute liver failure and pediatric ALF: strategic help for the pediatric hepatologist. J Pediatr. 2010 Feb;156(2):342.
  1. Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, Fracanzani AL, Lattuada E, Zappa MA, Roviaro G, Marchesini G, Day CP, Fargion S. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut. 2010 Feb;59(2):267-73.
  1. Alisi A, Comparcola D, Nobili V. Treatment of chronic hepatitis C in children: is it necessary and, if so, in whom? J Hepatol. 2010 Apr;52(4):472-4.
  1. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. 2010 Apr;51(4):1209-17
  1. Alisi A, Panera N, Nobili V. The link between hepatosteatosis and cells of the immune system. Hepatology. 2010 Apr;51(4):1472; author reply 1472-3.
  1. Nobili V, Pinzani M. Paediatric non-alcoholic fatty liver disease. 2010 May;59(5):561-4.

 

  1. Nobili V, Cianfarani S, Agostoni C Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle. J Hepatol. 2010 Jun;52(6):788-90.
  1. Nobili V, Bedogni G, Alisi A, Agostoni C. Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease. Hepatology. 2010 Jul;52(1):399.
  1. Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010 Jun;50(6):645-9.
  1. Nobili V, Candusso M, Torre G, de Ville de Goyet J. Steatosis and fibrosis in paediatric liver transplant: insidious graft’s enemies–a call for clinical studies and research. Pediatr Transplant. 2010 Jun;14(4):441-4.
  1. Nobili V, Alkhouri N, Bartuli A, Manco M, Lopez R, Alisi A, Feldstein AE. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease. Pediatr Res. 2010 Jun;67(6):665-70.
  1. Manco M, Ciampalini P, Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology. 2010 Jun;51(6):2229; author reply 2230.
  1. Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):397-402.
  1. Nobili V, Jenkner A, Francalanci P, Castellano A, Holme E, Callea F, Dionisi-Vici C. Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome. Pediatrics. 2010 Jul;126(1):e235-8.
  1. Valenti L, Nobili V, Fargion S. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med. 2010 Jul 8;363(2):194; author reply 195.
  1. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. 2010 Oct;52(4):1274-80.
  1. Feldstein AE, Nobili V. Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):378-9.
  1. Nobili V, Parola M, Alisi A, Marra F, Piemonte F, Mombello C, Sutti S, Povero D, Maina V, Novo E, Albano E. Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. Int J Mol Med. 2010 Oct;26(4):471-6.
  1. Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G, Pinzani M. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res. 2010 Oct;156(4):229-34.
  1. Manco M, Alisi A, Fernandez-Real J, Equitani F, Devito R, Valenti L, Nobili V. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. J Hepatol. 2011 Sep;55(3):647-53.
  1. Pietrobattista A, Luciani M, Abraldes JG, Candusso M, Pancotti S, Soldati M, Monti L, Torre G, Nobili V. Extrahepatic portal vein thrombosis in children and adolescents: Influence of genetic thrombophilic disorders. World J Gastroenterol. 2010 Dec 28;16(48):6123-7.
  1. Alisi A, Manco M, Pezzullo M, Nobili V. Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis. Hepatology. 2011 Jan;53(1):372-3.
  1. Alisi A, Bedogni G, De Vito R, Comparcola D, Manco M, Nobili V. Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. Dig Liver Dis. 2011 Feb;43(2):143-6.
  1. Comparcola D, Nobili V, Alisi A, Balsano C. Effect of treatment with polyunsaturated fatty acids on HCV- or diet-induced fatty liver. J Hepatol. 2011 Jun;54(6):1325-6.
  1. Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol. 2011 Feb;9(2):150-5.
  1. Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment. Ann Med. 2011 Feb 28. [Epub ahead of print]
  1. Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, De Vito R, Leoni S, Bottazzo GF, Masotti A, Nobili V. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest. 2011 Feb;91(2):283-93.
  1. Maiorana A, Nobili V, Calandra S, Francalanci P, Bernabei S, El Hachem M, Monti L, Gennari F, Torre G, de Ville de Goyet J, Bartuli A. Preemptive liver transplantation in a child with familial hypercholesterolemia. Pediatr Transplant. 2011 Mar;15(2):E25-9.
  1. Alisi A, Panera N, Balsano C, Nobili V. Activation of the endotoxin/toll-like receptor 4 pathway: the way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma. Hepatology. 2011 Mar;53(3):1069.
  1. Nobili V, Bedogni G, Alisi A, Pietrobattista A, Risé P, Galli C, Agostoni C. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child. 2011 Apr;96(4):350-3.
  1. Nobili V, Alisi A, de Ville de Goyet J. Metabolic syndrome and NASH recurrence after liver transplantation in children. Liver Transpl. 2011 May;17(5):620-1.
  1. Brufani C, Fintini D, Nobili V, Patera PI, Cappa M, Brufani M. Use of metformin in pediatric age. Pediatr Diabetes. 2011 Sep;12(6):580-8.
  1. Manco M, Alisi A, Mosca A, Nobili V. The wide spectrum of hepatic iron overload. Hepatology. 2011 Mar;53(3):1057-8;
  1. Alisi A, Agostoni C, Nobili V. Supplementation of Monounsaturated and Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome. Lipids. 2011 May;46(5):389-90.
  1. Alisi A, Bruscalupi G, Pastore A, Petrini S, Panera N, Massimi M, Tozzi G, Leoni S, Piemonte F, Nobili V. Redox homeostasis and posttranslational modifications/activity of phosphatase and tensin homolog in hepatocytes from rats with diet-induced hepatosteatosis. J Nutr Biochem. 2011 Mar 29. [Epub ahead of print]
  1. Alisi A, de Vito R, Monti L, Nobili V. Liver fibrosis in paediatric liver diseases. Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):259-68.
  1. Della Corte C, Carlucci A, Francalanci P, Alisi A, Nobili V. Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl. 2011 Jun 24;29(29-30):4654-6.
  1. Diamanti A, Sartorelli MR, Alterio A, Comparcola D, Corsetti T, Iacono A, Pizzichemi G, Nobili V, de Ville de Goyet J, Torre G. Successful tenofovir treatment for fulminant hepatitis B infection in an infant. Pediatr Infect Dis J. 2011 Oct;30(10):912-4.
  1. Della Corte C, Alisi A, Iorio R, Alterio A, Nobili V. Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother. 2011 Aug;12(12):1901-11.
  1. Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med. 2011 Jun 6;9:70.
  1. Nobili V, Monti L, Alisi A, Lo Zupone C, Pietrobattista A, Tomà P. Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol. 2011 Oct;41(10):1232-8.
  1. Nobili V, Pinzani M. Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. Alcohol Alcohol. 2011 Sep-Oct;46(5):627-9
  1. Manco M, Alterio A, Bugianesi E, Ciampalini P, Mariani P, Finocchi M, Agostoni C, Nobili V. Insulin dynamics of breast- or formula-fed overweight and obese children. J Am Coll Nutr. 2011 Feb;30(1):29-38.
  1. Maffeis C, Banzato C, Rigotti F, Nobili V, Valandro S, Manfredi R, Morandi A. Biochemical parameters and anthropometry predict NAFLD in obese children. J Pediatr Gastroenterol Nutr. 2011 Jun 20. [Epub ahead of print]
  1. Alisi A, Romania P, Nobili V, Locatelli F, Fruci D. Human hepatic stellate cells are liver-resident antigen presenting cells. 2011 Jul 2. doi: 10.1002/hep.24511. [Epub ahead of print]
  2. Panera N, Raso R, Nobili V, Alisi A. Dual role of survivin in non-alcoholic fatty liver disease. Liver Int. 2011 Apr 19. doi: 10.1111/j.1478-3231.2011.02533.x. [Epub ahead of print]
  1. Alisi A, Nobili V. Nonalcoholic fatty liver disease: Targeted therapy in children–what is the right way? Nat Rev Gastroenterol Hepatol. 2011 Jul 12;8(8):425-6.
  1. Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies. J Hepatol. 2011 Jul 12. [Epub ahead of print]
  1. Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, Dongiovanni P, Fracanzani AL, Alterio A, Roviaro G, Daly AK, Fargion S, Day CP. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol. 2011 Jul 21. [Epub ahead of print]
  1. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):190-5.
  1. Ceccarelli S, Panera N, Alisi A, Nobili V. Hepatic stellate cell proliferation: A potential role of protein kinase R. Hepatology. 2011 Oct;54(4):1484-5.
  1. Alisi A, Nobili V. Metabolic Syndrome and Alcohol Abuse: A Potential Hepatocarcinogenic Mix in Adolescents. Clin Gastroenterol Hepatol. 2011 Jul 30. [Epub ahead of print]
  1. Nobili V, Della Corte C, Monti L, Alisi A, Feldstein A. The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate? Ital J Pediatr. 2011 Aug 2;37:36.
  1. Valenti L, Nobili V. PNPLA3 I148M polymorphism and liver damage in obese children. J Pediatr. 2011 Nov;159(5):876.
  1. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol. 2011 Jul 14;17(26):3082-91.
  1. Nobili V, Sanyal AJ. Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. J Gastroenterol. 2011 Oct 8. [Epub ahead of print]
  1. Canani RB, Di Costanzo M, Leone L, Bedogni G, Brambilla P, Cianfarani S, Nobili V, Pietrobelli A, Agostoni C. Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev. 2011 Oct 18:1-8.
  1. Bianchi M, Rizza T, Verrigni D, Martinelli D, Tozzi G, Torraco A, Piemonte F, Dionisi-Vici C, Nobili V, Francalanci P, Boldrini R, Callea F, Santorelli FM, Bertini E, Carrozzo R. Novel large-range mitochondrial DNA deletions and fatal multisystemic disorder with prominent hepatopathy. Biochem Biophys Res Commun. 2011 Oct 18. [Epub ahead of print]
  1. Alisi A, Carsetti R, Nobili V. Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development. Hepatology. 2011 Nov;54(5):1500-1502.

 

Abstracts

  1. Barbato M, Nobili V et al.: Antigliadin antibodies (AGA) and antiendomysium antibodyes (AEA) on challenge. II° Joint Meeting of the British and Italian Societies of Paediatric and Gastroenterology
  1. Przemioslo RT, Kontakou M, Nobili V, Sturgess R, Ciclitira PJ. Interleukin-6 and TNF-alfa in coeliac mucosa detected by immunohistochemistry and in-situ hybridisation. 1993;34;S4,T94
  1. Nobili V, Devito R, Comparcola D, Sartorelli MR, Marcellini M: Circulating levels of proinflammatory cytokines in children with obstructive jaundice. Fifth Joint Meeting of the British and Italian Societies of Paediatric Gastroenterology and Hepatology. May 8-10, 2003 Lucca – Italy
  1. Nobili V, Pastore A, Gaeta L, Tozzi G, Marcellini M, Bestini E, Piemonte F: Glutathione blood profile in children affected by NASH. J Pediatr Gastroenterol Nutr. 2004;39:s52
  1. Ciampalini P, Nobili V, Cappa M, Sartorelli MR, Barbetti F. Glucose tolerance in children and adolescents with nonalcoholic steatohepatitis (NASH). Diabetes. JUN 2004 ; 53 : A427-A427. Suppl. 2
  1. Nobili V, Sartorelli MR, Comparcola D, Guidi R, Marcellini M. Food allergy in children with liver transplantation: Harmful or harmless. Pediatric Transplantation.2005;9:74-74 Suppl. 6
  1. Nobili V, Devito R, Comparcola D, Sartorelli MR, Guidi R, Manco M, Alisi A, Tozzi G, Passarelli C, Gaeta L, Fruhwirth R, Piemonte F, Marcellini M. Protein glutathionylation increases in liver of patients with nonalcoholic fatty liver disease (nafld)
    Dig Liver Dis Oct 2007;39(10) A85-A85.
  1. Marcellini M, Pietrobattista A, Sartorelli MR, Comparcola D, Giovannelli L, Girolami E, Guidi R, Nobili V. Treatment of autoimmune hepatitis from the time of diagnosis in paediatric patients: A single-hospital long-term follow-up study.
    Dig Liver Dis Oct 2007; 39 (10): A84-A84
  1. Nobili V, Petrini S, Devito R, Lancella L, Stella P, Russo C, Comparcola D, Sartorelli MR, Marcellini M Acute liver failure following measles virus infection. Dig Liver Dis Oct 2007;39(10): A69-A70.
  1. Nobili V, Manco M, DeVito R, PietroBattista A, Comparcola D, Sartorelli MR, Piemonte P, Marcellini M. Angulo P. Lifestyle intervention and antioxidants in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Gastroenterology 2008;134(4): A781-A781.
  1. Nobili V, Di Ciommo V, Sartorelli MR, Comparcola D, Marcellini M, Maggi F: TT virus in children affected by liver diseases. J Infect 2005;50(4):368-369
  1. Nobili V, Devito R, Russo C, Dionisi-Vici C, Marcellini M: Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):339.
  1. Comparcola D, Nobili V, Sartorelli MR, Marcellini M, Cainelli R, Vento S: HCV in children. J Gastroenterol Hepatol. 2005 Dec;20(12):1948-9.
  1. Nobili V, Vento S, Dionisi-Vici C, Sartorelli MR, Russo C, and Marcellini M: Acute liver faille as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):339.24.
  1. Vento S, Nobili V, Cainelli F: Clinical course of infection with hepatitis C. BMJ. 2006 Feb 18;332(7538):374-5.
  1. Nobili V, Marcellini M, Devito R, Ciampalini P, Comparcola D, Sartorelli MR, Piemonte F, Angulo PH: NAFLD in children: A single-center experience. JPGN 2006, 42, 5
  1. Marcellini M, Sartorelli MR, Nobili V. Reply to T.U. Hoogenraad’s paper published in the last April. Brain Dev. 2007 Jan;29(1):55
  1. Guidi R, Nobili V, Marcellini M: Editorial Food allergy in pediatric liver transplantation: harmful o harmless? Pediatr Transplant. 2007 Feb;11(1):1-2
  1. Nobili V, et al. Diet and exercise improve liver function and insulin resistance in children with NAFLD. Nature Clinical Practice Gastroenterol & Hepatol 2007;4:126
  1. Marchesini G, Nobili V, Bugianesi E. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007 Oct;30(11):e125.
  1. Manco M, Marcellini M, Nobili V: Lifestyle advice in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007 Apr;22(4):604-5.
  1. Sartorelli MR, Nobili V, Comparcola D, Monti L, Guidi R, and Marcellini M: Looking for evidence between split liver transplantation and portal hypertension. Ped Transplantation 2007;11:S1:93.
  1. Al-Serri A., Nobili V, Daly A.K, Marcellini M, Alisi A, Manco M, Leathart J.B.S, Graham J, Day CP. The mitochondrial superoxide dismutase 2 (SOD2) targeting sequence polymorphism is associated with fibrotic NAFLD: Consistent evidence from case-control and intra-familial allelic association studies. Meeting BASL 2007 (Londra).
  1. Alisi A, Gaeta L.M, Piemonte F, Petrini S, Manco M, Marcellini M, Nobili V. “Impact of NF-κB glutathionylation in redox regulation of HepG2”. Meeting EASL 2008 (Milano); J Hepatol 2008 (Vol. 48, Page S162).
  1. Alisi A., Piemonte F., Gaeta L.M., Marcellini M., Nobili V. “Oxidative stress alters survival and insulin-related pathways inducing damage in HepG2 cells”. Meeting DDW 2008 (San Diego);Gastroenterology. April 2008 (Vol. 134, Issue 4, Pages A-413).
  1. Alisi A, Piemonte F, Gaeta LM., Passarelli C, Tozzi G., Petrini S, Marcellini M, Bottazzo GF, Nobili V. “Pro- and anti-oxidants modulate the balance between apoptosis and proliferation in hepatoma cells by regulating NF-κB glutathionylation ”. Meeting AASLD (Boston). Hepatology 2008;48, 4.
  1. Alisi A., Masotti A., Da Sacco L., Piemonte F, Devito R., Alterio A, Bruscalupi G, Leoni S, Bottazzo GF, Nobili V. “MicroRNA expression profiles in liver tissues from rat fed high fat/high carbohydrate diet may help to elucidate molecular pathogenesis of non alcoholic fatty liver disease”. Meeting EASL 2009 (Copenhagen); J Hepatol 2008;50: S254.
  1. Alisi A., Piemonte F., Bruscalupi G., Pastore A., Massimi M., Tozzi. , Leoni S, Nobili V. “Emodin protects primary rat hepatocytes from pro-oxidative effects and AKT pathway dysregulation induced by a high-fat/low carbohydrate diet”. Meeting EASL 2009 (Copenhagen); J Hepatol 2009; 50:S255.
  1. Alisi A, Pastore A, Passarelli C, Tozzi G, Bottazzo GF, Nobili V, Piemonte F. “Glutathionylation of p65NF-KB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxisants”. SFRR-Europe Meeting 2009 (Roma). Free Radic Res 2009; 43: suppl.1, S59.
  1. Pastore A, Piemonte F, Bruscalupi G, Massimi M., Tozzi G., Leoni S, Nobili V, Alisi A. “Hepatoprotective and anti-oxidant effects of emodin on primary rat hepatocytes isolated from rats fed with a high-fat/low carbohydrate diet”. SFRR-Europe Meeting 2009 (Roma). Free Radic Res 2009; 43, suppl.1, S79.
  1. Nobili V, Alkhouri N, Manco M., Ottino S, Lopez R., Alisi A., and Feldstein A. “Retinol-binding protein 4: a promising circulating marker of liver damage in children with non-alcoholic fatty liver desease”. Meeting EASL 2009 (Copenhagen); J Hepatol 2009;50: S367
  1. Nobili V, Alkhouri N, Alisi A, Manco M, Bartuli A, Lopez R, Feldstein A. “Severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver desease”. Meeting DDW 2008 (San Diego); Gastroenterology May 2009;136(5); A-845.
  1. Panera N, Alisi A, Masotti A, Da Sacco L, Pezzullo, Devito R, Bruscalupi G, Leoni S, Manco M, Nobili V. “Inflammatory molecole involved in non-alcoholic steatohepatitis in rats fed different diets. Meeting AISF 2010 (Roma); Dig Liver Dis 2010; 42, Suppl. S47.
  1. Alisi A, Bruscalupi G, Pastore A, Petrini S, Massimi M, Tozzi G, Leoni S, Piemonte F, Nobili V. “Redox homeostasis and phosphatise and tensin homolog (PTEN) activity in primary hepatocytes fraom rat fed with different dietes”. EMBO CONFERENCE: Cellular Signalling And Molecular Medicine 2010 (Cavtat, Dubrovnik, Croatia).
  1. Alisi A, Panera N, Masotti A, Da Sacco L, Pezzullo M, De Vito R, Bruscalupi G, Leoni S, Manco M, Nobili V. “Molecular mechanism of the inflammatory response in the liver of rats with non-alcoholic steatohepatitis induced by different dietetic regimens. EMBO Conference: Cellular Signalling And Molecular Medicine 2010 (Cavtat, Dubrovnik, Croatia).
  1. Alisi A, Manco M, De Vito R, Citti A, Pietrobattista A, Alterio A, Wietrzykowska Sforza R., Nobili V. “Intra-hepatic iron deposition correlates with non-allcoholic steatohepatitis in children” ESPGHAN 2010 Congress (Istanbul, Turkey). J Pediatr Gastroenterol Nutr 2010;50, Suppl. 2: E36-E36.
  1. Alisi A, Panera N, Masotti A, Da Sacco L, Pezzullo M, De Vito R, Petrini S, Manco M,   Nobili V. Lipopolysaccharide-induced tumor necrosis factor-a (LITAF) and non-alcoholic fatty liver disease (NAFLD). SIGENP 2010 (Montesilvano, Pescara, Italy). Dig Liver Dis 2010; 42, Suppl. 5: S331.
  1. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol; 2010: 52 : S57-S57.
  1. Alkhouri N, Nobili V, Carter-Kent CA, Lopez R, Pinzani M, Bedogni G , Feldstein AE. Performance of the pediatric Nafld fibrosis index and transient elastography in predicting the presence of clinically significant fibrosis in children with non-alcoholic fatty liver disease: a prospective study. Hepatology. Oct 2010; 52, 4: 348A-348A.
Send this to a friend